sinopharm

Riboxx Pharma, China National Biotec Group To Collaborate On TLR3 Agonist

Riboxx Pharmaceuticals GmbH and China National Biotec Group have initiated a research collaboration to evaluate a TLR3 agonist from Riboxx.

Non-Profit Aeras & China National Biotech To Collaborate On TB Vaccine

Aeras and the China National Biotech Group (CNBG) announced a collaboration to jointly develop tuberculosis vaccines in China and potentially other parts of the world.